John W. Wright
Regents Professor
Ph.D. Michigan State University, 1971
Contact Information
Email: wrightjw@wsu.edu
Office: Johnson Tower 124
Phone: (509) 335-2329
(509) 592-6479
Classes Taught
- Psychology 502: Research Design
- Psychology 505: Teaching Psychology
- Psychology 574: Physiological Psychology
Research Interests
- Alzheimer’s Disease
- Neurochemistry of Memory Consolidation
- Parkinson’s Disease
- Stroke related motor dysfunctions
Selected Publications
Wright, JW, Murphy ES, Wiediger RV, Murphy KL, Harding JW. (2013). Important roles for matrix metalloproteinases and cell adhesion molecules in LTP, habituation, and drug addiction. In Habituation: Theories, Characteristics and Biological Mechanisms. Nova Publishers, Hauppauge, NY. (in press)
Natarajan R, Wright JW, Harding JW. (2013). Matrix metalloproteinase activity is required for nicotine-induced conditioned place preference and context dependent relapse in adolescent female rats. Journal of Experimental Neuroscience, 7: 1-14.
Wright, J.W. and Harding, J.W. (2013). The development of multi-target-directed ligands (MTDL) to treat Alzheimer’s Disease. In Atta-ur-Rahman (Ed.), Frontiers in Clinical Drug Research – Alzheimer Disorders. Bentham Science Publishers, Vol. 1, pp. 1-18, e-book series. (Invited chapter).
Wright, J.W. and Harding, J.W. (2013). The brain renin-angiotensin system: A diversity of functions and implications for CNS diseases. Pflȕgers Archives – European Journal of Physiology, 465:133-151. (Invited review).
McCoy, A.T., Benoist, C.C., Kawas, L.H., Bule, J., Zhu, M., Appleyard, S.M., Wayman, G.A., Wright, J.W., and Harding, J.W. (2012). Evaluation of metabolically stabilized angiotensin IV analogs as pro-cognitive/anti-dementia agents. Journal of Pharmacological and Experimental Therapeutics, 344:141-154.
